SAB5200294
单克隆抗-Mmp9 小鼠抗
clone S51-82, purified immunoglobulin
别名:
抗-82kDa基质金属蛋白酶-9, 抗-CLG4B, 抗-GELB, 抗-MANDP2, 抗-MMP-9
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
S51-82, monoclonal
Application:
IHC, IP, WB
Citations:
3
biological source
mouse
Quality Level
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
S51-82, monoclonal
form
buffered aqueous solution
mol wt
antigen predicted mol wt 92 & 82 kDa
species reactivity
mouse, human, rat
concentration
1 mg/mL
technique(s)
immunohistochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable
isotype
IgG2a
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
rat ... Mmp9(81687)
Immunogen
大鼠MMP9的融合蛋白氨基酸1-708（全长）
Biochem/physiol Actions
可检测~92kDa和~82kDa（前体和活性形式）
Features and Benefits
完放心地使用我们的抗体。如果抗体在您的申请的研究中不起作用，我们将全额退款或安排替代抗体。了解更多信息。
Physical form
PBS，pH7.4，50%甘油，0.09%叠氮化钠
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Still not finding the right product?
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
低风险生物材料
常规特殊物品
此项目有
Xin Yin et al.
Frontiers in pharmacology, 13, 913098-913098 (2022-08-30)
ShengFu oil is a compounded Chinese medicinal prescription, and provides antibacterial, anti-inflammatory, and analgesic effects, favoring burn wound repair. In this study, we aimed at investigating the effects of topical applications of ShengFu oil and its active ingredients in oral
Jih-Hua Wei et al.
International journal of molecular sciences, 24(6) (2023-03-30)
Bariatric surgery reduces body weight, enhances metabolic and diabetic control, and improves outcomes on obesity-related comorbidities. However, the mechanisms mediating this protection against cardiovascular diseases remain unclear. We investigated the effect of sleeve gastrectomy (SG) on vascular protection in response
Zhi Teng et al.
Oncology reports, 43(2), 503-515 (2020-01-03)
Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SAB5200294-100UG | 04061832155791 |